Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Standard versus tailored combined oral contraceptive use for 12-month continuation
2007-005453-36Phase 4Completed
- Sponsor
- Central and North West London NHS Foundation Trust
- Start
- Jan 2008
- Modality
- Small Molecules
- Countries
- 1
01
Overview
Phase 4, randomised, open-label trial of ethinylestradiol + levonorgestrel in contraception (2 arms), sponsored by Central and North West London NHS Foundation Trust. Primary endpoint: Continuation of combined oral contraceptive use at 12 months. Started Jan 2008; status: completed.
02
Drugs
ethinylestradiol + levonorgestrel
03
Conditions
contraception
Beyond the preview
Go deeper on 2007-005453-36.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on 2007-005453-36.